Premium
Mixed microbial aetiology of community‐acquired pneumonia in children
Author(s) -
Korppi MATTI
Publication year - 2002
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1034/j.1600-0463.2002.11007801.x
Subject(s) - pneumonia , bacterial pneumonia , etiology , community acquired pneumonia , immunology , serology , medicine , viral pneumonia , respiratory tract infections , virus , antibiotics , virology , biology , respiratory system , microbiology and biotechnology , disease , covid-19 , antibody , infectious disease (medical specialty)
Seven paediatric studies on community‐acquired pneumonia with serological methods for both viruses and bacteria have been published, allowing the evaluation of concomitant multiple etiological findings. In these studies, dual viral infection has been present in 0–14%, dual bacterial infection likewise in 0–14%, and mixed viral‐bacterial infection in 3–30% of the pneumonia cases. The results confirm former clinical observations that respiratory viruses often pave the way for airway‐colonising bacteria. The measured frequency of multiple infections has been dependent on the available test panel, mainly on the tests used for pneumococcal aetiology. Mixed viral‐bacterial infections have been especially co‐mmon in young children under 2 years of age, reflecting the high frequency of respiratory syncytial virus infections and their tendency to induce bacterial co‐infections. No microbe‐specific viral‐bacterial associations have been demonstrated. The clinical implications of mixed viral‐bacterial infections, compared with viral infections alone or bacterial infections alone, have so far remained unresolved. Current guidelines recommend antibiotic therapy for all community‐acquired pneumonia cases in children.